Michael Titus has served for over 2 years as the Vice President of Operations & Quality for Avobis Bio, a cell therapy joint venture formed between the Mayo Clinic and W.L. Gore & Associates, Inc. In this role, he has helped guide the development of clinical manufacturing, quality systems and regulatory path for a combination stem cell/bioscaffold product. He began his career manufacturing vaccines at Connaught Laboratories after receiving a Ph.D. in medical microbiology and immunology from the Pennsylvania State University in Hershey. His subsequent experience includes small molecule drug development, monoclonal antibody and recombinant protein manufacturing, medical device quality systems and regulatory affairs, along with start-up and established organizational management.